pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ultragenyx Pharmaceutical Inc. ($RARE) · news · pharmadog
← back to Ultragenyx Pharmaceutical Inc.
News mentioning $RARE
833
stories
Aug 7, 26
BioMarin axes $270M rare disease asset after missing phase 3 endpoint
fiercebiotech
Aug 6, 26
Third time’s the charm for Replimune as melanoma drug earns FDA greenlight
biospace
Aug 6, 26
STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more
stat
Aug 6, 26
Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
stat
Aug 6, 26
Covid can reactivate dormant viruses, according to study
stat
Aug 6, 26
CROs vs. biotechs: Finding the right fit
biospace
Aug 6, 26
Medline Industries, LP Issues Nationwide Recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits
fda medwatch
Aug 6, 26
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology
stat
Aug 6, 26
Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS
raps
Aug 5, 26
STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
stat
Aug 5, 26
STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
stat
Aug 5, 26
FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
fda press
Aug 5, 26
Erica Schwartz confirmed as CDC director, filling nearly yearlong vacancy
stat
Aug 5, 26
STAT+: Could poop pills be the next treatment for food allergies?
stat
Aug 5, 26
STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety
stat
Aug 5, 26
Bespoke gene-editing outfit abandons lead program, cuts ‘several’ employees
biospace
Aug 5, 26
Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad
biospace
Aug 5, 26
STAT+: Moderna launches early trial of Ebola mRNA vaccine
stat
Aug 5, 26
STAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and more
stat
Aug 5, 26
Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms
biospace
Aug 5, 26
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
stat
Aug 5, 26
STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds
stat
Aug 5, 26
4 potential biotech M&A targets, plus a pretty sure bet from J&J
biospace
Aug 4, 26
Blank Slate Creamery Issues Allergy Alert on Undeclared Egg in Vegan Non-Dairy Frozen Dessert Coconut Fudge Sandwiches
fda recalls
Aug 4, 26
STAT+: Startup promising to scale custom CRISPR therapies abruptly scraps plans
stat
Aug 4, 26
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
Aug 4, 26
STAT+: The latest orphan drug exemptions may not be warranted, analysis finds
stat
Aug 4, 26
Merck's anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in SSc-ILD
endpoints
Aug 3, 26
BioNTech taps Sobi executive Oelkers as its next CEO
biopharma dive
Aug 3, 26
Boticelli Foods Recalls Bettergoods Pistachio Nut Butter Because of Possible Health Risk
fda recalls
← prev
page 15 of 28
next →
